ISPOR - From Centralized Marketing Authorization to National Reimbursement – A Challenging Journey for New Medical Products with Placebo Controlled Trials

Full Text

From Centralized Marketing Authorization to National Reimbursement – A Challenging Journey for New Medical Products with Placebo Controlled Trials

Abstract

Authors

D Eheberg G Paulus S Dannemann A Batscheider

Back to Volume 18, Issue 7

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now